. "1"^^ . . "Herpes zoster and possibilities of immunisation"@en . . "1"^^ . . "RIV/60162694:G44__/08:00002078!RIV09-MO0-G44_____" . "Herpes zoster is a skin disease afflicting corresponding dermatoma with vesicular exanthema. Varicella-zoster virus is causing agent. Herpes Zoster is a consequence of reactivation of latent varicella-zoster virus, which as primary infection causes shingles during primary infection. The most frequent debilitating complication seems to be postherpetic neuralgia and neuropathic pain syndrom, which persists or develops after rash being resolved in dermatomal area. Frequency and severity of postherpetic neuralgia increase with advancing age. The only registered vaccine up to now is live attenuated vaccine ZOSTAVAX. A future alternative should be subunit recombinant vaccines."@en . "Herpes zoster a mo\u017Enosti vakcinace"@cs . "369989" . "3" . . "Herpes zoster and possibilities of immunisation"@en . "8"^^ . . "Chl\u00EDbek, Roman" . . "1802-3150" . "Herpes zoster a mo\u017Enosti vakcinace" . "Herpes zoster a mo\u017Enosti vakcinace" . . "Herpes zoster a mo\u017Enosti vakcinace"@cs . . "RIV/60162694:G44__/08:00002078" . "[22EA36008668]" . "Varicella-herpes zoster virus; shingles; posteherpetic neuralgia; incidence; immunization; immunogenicity; reactogenicity"@en . "2" . . "Z(MO0FVZ0000502)" . . . "P\u00E1sov\u00FD opar je ko\u017En\u00ED infekce, kter\u00E1 postihuje p\u0159\u00EDslu\u0161n\u00FD dermatom vezikul\u00E1rn\u00EDm exant\u00E9mem. P\u016Fvodcem je virus varicella zoster. Onemocn\u011Bn\u00ED herpes zoster je v\u00FDsledkem reaktivace latentn\u00EDho varicella -zoster viru, kter\u00FD vyvol\u00E1v\u00E1 p\u0159i primoinfekci plan\u00E9 ne\u0161tovice. Nej\u010Dast\u011Bj\u0161\u00ED zneschop\u0148uj\u00EDc\u00ED komplikac\u00ED je postherpetick\u00E1 neuralgie, neuropatick\u00FD bolestiv\u00FD syndrom, kter\u00FD p\u0159etrv\u00E1v\u00E1 nebo se vyv\u00EDj\u00ED pot\u00E9, co se vyl\u00E9\u010Dil rash v oblasti dermatomu. Frekvence a z\u00E1va\u017Enost postherpetick\u00E9 neuralgie tak\u00E9 nar\u016Fst\u00E1 se stoupaj\u00EDc\u00EDm v\u011Bkem. Jedinou registrovanou vakc\u00EDnou je \u017Eiv\u00E1 oslaben\u00E1 vakc\u00EDna ZOSTAVAX. Budouc\u00ED alternativou by m\u011Bly b\u00FDt subjednotkov\u00E9 rekombinantn\u00ED o\u010Dkovac\u00ED l\u00E1tky."@cs . "G44" . "P\u00E1sov\u00FD opar je ko\u017En\u00ED infekce, kter\u00E1 postihuje p\u0159\u00EDslu\u0161n\u00FD dermatom vezikul\u00E1rn\u00EDm exant\u00E9mem. P\u016Fvodcem je virus varicella zoster. Onemocn\u011Bn\u00ED herpes zoster je v\u00FDsledkem reaktivace latentn\u00EDho varicella -zoster viru, kter\u00FD vyvol\u00E1v\u00E1 p\u0159i primoinfekci plan\u00E9 ne\u0161tovice. Nej\u010Dast\u011Bj\u0161\u00ED zneschop\u0148uj\u00EDc\u00ED komplikac\u00ED je postherpetick\u00E1 neuralgie, neuropatick\u00FD bolestiv\u00FD syndrom, kter\u00FD p\u0159etrv\u00E1v\u00E1 nebo se vyv\u00EDj\u00ED pot\u00E9, co se vyl\u00E9\u010Dil rash v oblasti dermatomu. Frekvence a z\u00E1va\u017Enost postherpetick\u00E9 neuralgie tak\u00E9 nar\u016Fst\u00E1 se stoupaj\u00EDc\u00EDm v\u011Bkem. Jedinou registrovanou vakc\u00EDnou je \u017Eiv\u00E1 oslaben\u00E1 vakc\u00EDna ZOSTAVAX. Budouc\u00ED alternativou by m\u011Bly b\u00FDt subjednotkov\u00E9 rekombinantn\u00ED o\u010Dkovac\u00ED l\u00E1tky." . . "Vakcinologie" . . "CZ - \u010Cesk\u00E1 republika" . . . . . .